MedPath
HSA Approval

MONTELUKAST SANDOZ FILM COATED TABLET 10MG

SIN14385P

MONTELUKAST SANDOZ FILM COATED TABLET 10MG

MONTELUKAST SANDOZ FILM COATED TABLET 10MG

July 23, 2013

NOVARTIS (SINGAPORE) PTE LTD

SANDOZ SINGAPORE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantNOVARTIS (SINGAPORE) PTE LTD
Licence HolderSANDOZ SINGAPORE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

R03DC03

montelukast

Manufacturer Information

SANDOZ SINGAPORE PTE. LTD.

Genveon Ilac Sanayi ve Ticaret A.S

Lek S.A (Strykow)

Lek S.A. (Warszawa) (Primary and secondary packager)

Active Ingredients

Montelukast sodium 10.40mg equivalent Montelukast

10mg

Montelukast

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.